1 not yet recruiting, 1 terminated. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
Follow IV naloxone: new trials by email Literature Review of IV naloxone trials Research Report on IV naloxone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sedation and Guided Education for Depression Study Response-focused education, Diagnosis-focused education, IV naloxone - Major Depressive Disorder (MDD) | Not applicable | Not yet recruiting | Stanford University | 40 | 2026-09-01 | 2026-10-27 |
| Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists Narcan 40 MG/ML Nasal Spray, Naloxone Hydrochloride, Nalmefene HCl injection - Opioid Induced Respiratory Depression, Chronic Opioid Use | Phase 1 | Terminated | Leiden University Medical Center | 58 | 2022-06-24 | 2026-07-29 |
Depressive Disorder, Major (1)
Leiden University Medical Center (1) · Stanford University (1)
Netherlands (1)
Rutger van der Schrier, MD (1)